Title | The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease |
Authors | Kim, Hyun Kuk Tantry, Udaya S. Smith, Sidney C., Jr. Jeong, Myung Ho Park, Seung-Jung Kim, Moo Hyun Lim, Do-Sun Shin, Eun-Seok Park, Duk-Woo Huo, Yong Chen, Shao-Liang Bo, Zheng Goto, Shinya Kimura, Takeshi Yasuda, Satoshi Chen, Wen-Jone Chan, Mark Aradi, Daniel Geisler, Tobias Gorog, Diana A. Sibbing, Dirk Lip, Gregory Y. H. Angiolillo, Dominick J. Gurbel, Paul A. Jeong, Young-Hoon |
Affiliation | Chosun Univ Hosp, Dept Cardiol, Gwangju, South Korea Sinai Hosp Baltimore, Sinai Ctr Thrombosis Res, Baltimore, MD USA Univ N Carolina, Div Cardiol, Chapel Hill, NC USA Chonnam Natl Univ Hosp, Dept Cardiol, Gwangju, South Korea Univ Ulsan, Heart Inst, Asan Med Ctr, Seoul, South Korea Dong A Univ Hosp, Dept Cardiol, Busan, South Korea Korea Univ, Dept Cardiol, Cardiovasc Ctr, Anam Hosp, South, Seoul, South Korea Ulsan Hosp, Div Cardiol, Ulsan, South Korea Peking Univ First Hosp, Dept Cardiol, Beijing, Peoples R China Nanjing Med Univ, Nanjing First Hosp, Cardiovasc Dept, Nanjing, Peoples R China Tokai Univ, Sch Med, Dept Med Cardiol, Tokai, Kanagawa, Japan Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan Natl Taiwan Univ Hosp, Cardiol Div, Dept Internal Med, Taipei, Taiwan Natl Univ Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore Semmelweis Univ, Heart Ctr Balatonfured, Budapest, Hungary Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary Univ Hosp Tubingen, Dept Cardiol & Cardiovasc Med, Tubingen, Germany Imperial Coll, Natl Heart & Lung Inst, London, England Univ Hertfordshire, Postgrad Med Sch, Hatfield, Herts, England LMU Munchen, Dept Cardiol, Munich, Germany DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site, Munich, Germany Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England Univ Liverpool, Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA Gyeongsang Natl Univ, Sch Med & Cardiovasc Ctr, Dept Internal Med, Changwon Hosp, Chang Won, South Korea Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea |
Keywords | PERCUTANEOUS CORONARY INTERVENTION CLOPIDOGREL PLATELET REACTIVITY EXPERT CONSENSUS STATEMENT DUAL ANTIPLATELET THERAPY CAROTID-ARTERY-DISEASE ATRIAL-FIBRILLATION RACIAL-DIFFERENCES CLINICAL-OUTCOMES STENT THROMBOSIS MYOCARDIAL-INFARCTION |
Issue Date | Apr-2021 |
Publisher | THROMBOSIS AND HAEMOSTASIS |
Abstract | East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y (12) receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk-benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients. |
URI | http://hdl.handle.net/20.500.11897/621727 |
ISSN | 0340-6245 |
DOI | 10.1055/s-0040-1718729 |
Indexed | SCI(E) |
Appears in Collections: | 第一医院 |